1. Home
  2. OPAD vs STIM Comparison

OPAD vs STIM Comparison

Compare OPAD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OPAD

Offerpad Solutions Inc.

HOLD

Current Price

$0.76

Market Cap

36.9M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.31

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAD
STIM
Founded
2015
2003
Country
United States
United States
Employees
140
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
105.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
OPAD
STIM
Price
$0.76
$1.31
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$1.83
$7.00
AVG Volume (30 Days)
1.4M
2.5M
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
$10.89
$101.67
Revenue Next Year
$15.60
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.20
52 Week High
$6.35
$5.91

Technical Indicators

Market Signals
Indicator
OPAD
STIM
Relative Strength Index (RSI) 35.69 40.81
Support Level N/A $1.24
Resistance Level $1.18 $2.13
Average True Range (ATR) 0.08 0.16
MACD 0.02 -0.01
Stochastic Oscillator 20.24 11.10

Price Performance

Historical Comparison
OPAD
STIM

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: